Past events
View our past events
Argentina Pharmaceutical Science Symposium: From Predictive Science to Regulation
Symposium
- 13 March 2026
- English, Spanish
- In-person
Lhasa Limited is pleased to announce that we will host a symposium in Buenos Aires, Argentina in March 2026.
For our trip to South America for a co-hosted event with our subsidiary, Consult Lhasa, we have tailored the agenda to address regional regulatory expectations while aligning with international best practices for chemical safety assessments.
ICH S1B(R1) industry and regulatory best practice for confident carcinogenicity assessment (in Japanese)
Webinar
- 10 March 2026
- Japanese
- Online
This webinar is a replay designed for our Japanese-speaking scientific community, with presentations available as recordings featuring embedded Japanese subtitles.
The ICH S1B(R1) addendum is a globally recognised guideline that introduces a weight-of-evidence (WoE) approach to assessing the carcinogenic potential of pharmaceuticals.
10th Impurities: Genotoxic, Nitrosamine, & Beyond Summit
Conference
- 4 - 5 March 2026
- English
- In-person
The 10th Impurities: Genotoxic, Nitrosamine & Beyond Summit I #Egenotoxic 2026 is one of the most respected and widely attended gatherings in the field of pharmaceutical impurity control.
Forced degradation problem solving (in Japanese)
Webinar
- 24 February 2026
- Japanese
- Online
強制分解の問題解決
This session was hosted in Japanese or with Japanese subtitles.
Supporting forced degradation studies with in silico tools as part of your workflow.
From theory to practice: How to apply ICH M7(R2) in the assessment of (potentially) mutagenic impurities
Webinar
- 11 December 2025
- Portuguese
- Online
Thursday 11th December
13:00 – 15:00 (BRT)
This webinar was delivered entirely in Portuguese.
Are you looking to strengthen your understanding of the ICH M7(R2) guideline and learn practical approaches to conducting compliant impurity risk assessments?